3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide

C104H115N27O13S — CID 161092918

IUPAC3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide
SMILESCOc1ccc(S(=O)(=O)N2CCCC2)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.Cc1ccc(COc2occc2C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)cc1.Cn1nc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1(c2ccccc2)CC1
InChIInChI=1S/C28H28N6O4.C27H31N7O5S.C25H26N6O2.C24H30N8O2/c1-18-2-4-19(5-3-18)17-38-28-21(8-11-37-28)27(35)32-24-15-29-33-25(24)26-30-22-7-6-20(14-23(22)31-26)16-34-9-12-36-13-10-34;1-38-24-7-5-19(40(36,37)34-8-2-3-9-34)15-20(24)27(35)31-23-16-28-32-25(23)26-29-21-6-4-18(14-22(21)30-26)17-33-10-12-39-13-11-33;32-24(25(8-9-25)18-4-2-1-3-5-18)29-21-15-26-30-22(21)23-27-19-7-6-17(14-20(19)28-23)16-31-10-12-33-13-11-31;1-24(2,3)20-12-19(31(4)30-20)23(33)28-18-13-25-29-21(18)22-26-16-6-5-15(11-17(16)27-22)14-32-7-9-34-10-8-32/h2-8,11,14-15H,9-10,12-13,16-17H2,1H3,(H,29,33)(H,30,31)(H,32,35);4-7,14-16H,2-3,8-13,17H2,1H3,(H,28,32)(H,29,30)(H,31,35);1-7,14-15H,8-13,16H2,(H,26,30)(H,27,28)(H,29,32);5-6,11-13H,7-10,14H2,1-4H3,(H,25,29)(H,26,27)(H,28,33)
InChIKeyUHKMKZZUHBYJFD-UHFFFAOYSA-N
MW1983.31 g/mol
LogP13.87
Rot. Bonds27

About 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide

3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide (PubChem CID 161092918) has the molecular formula C104H115N27O13S and a molecular weight of 1983.31 g/mol. Its IUPAC name is 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide.

Molecular Properties

Compound Name3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide
PubChem CID161092918
Molecular FormulaC104H115N27O13S
Molecular Weight1983.31 g/mol
Exact Mass1981.89
IUPAC Name3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide
SMILESCOc1ccc(S(=O)(=O)N2CCCC2)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.Cc1ccc(COc2occc2C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)cc1.Cn1nc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1(c2ccccc2)CC1
InChIInChI=1S/C28H28N6O4.C27H31N7O5S.C25H26N6O2.C24H30N8O2/c1-18-2-4-19(5-3-18)17-38-28-21(8-11-37-28)27(35)32-24-15-29-33-25(24)26-30-22-7-6-20(14-23(22)31-26)16-34-9-12-36-13-10-34;1-38-24-7-5-19(40(36,37)34-8-2-3-9-34)15-20(24)27(35)31-23-16-28-32-25(23)26-29-21-6-4-18(14-22(21)30-26)17-33-10-12-39-13-11-33;32-24(25(8-9-25)18-4-2-1-3-5-18)29-21-15-26-30-22(21)23-27-19-7-6-17(14-20(19)28-23)16-31-10-12-33-13-11-31;1-24(2,3)20-12-19(31(4)30-20)23(33)28-18-13-25-29-21(18)22-26-16-6-5-15(11-17(16)27-22)14-32-7-9-34-10-8-32/h2-8,11,14-15H,9-10,12-13,16-17H2,1H3,(H,29,33)(H,30,31)(H,32,35);4-7,14-16H,2-3,8-13,17H2,1H3,(H,28,32)(H,29,30)(H,31,35);1-7,14-15H,8-13,16H2,(H,26,30)(H,27,28)(H,29,32);5-6,11-13H,7-10,14H2,1-4H3,(H,25,29)(H,26,27)(H,28,33)
InChIKeyUHKMKZZUHBYJFD-UHFFFAOYSA-N
XLogP13.87
TPSA482.52 Ų
H-Bond Donors12
H-Bond Acceptors27
Rotatable Bonds27
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001983.31
LogP ≤ 513.87
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1027

Analyze 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-fluoro-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-(trifluoromethyl)benzamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(phenoxymethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-phenyl-1,3-oxazole-4-carboxamide
CID 159112524
2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenoxy)methyl]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1H-pyrrole-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(phenoxymethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide
CID 159289866
2-amino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylacetamide;2,2-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3H-1-benzofuran-7-carboxamide;3-(4-fluorophenyl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,2-oxazole-4-carboxamide;5-(2-methylpropyl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,2-oxazole-3-carboxamide;3-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
CID 159440197
2,6-difluoro-N-[5-[6-[[4-(4-methylcyclohexyl)piperazin-1-yl]methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-(6-morpholin-4-ylsulfonyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-2-carboxamide
CID 159649004
3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenoxy)methyl]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2,1-benzoxazole-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(phenoxymethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide
CID 160651290
tert-butyl N-[2-[[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]amino]-2-oxo-1-phenylethyl]carbamate;2,2-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3H-1-benzofuran-7-carboxamide;5-(2-methylpropyl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,2-oxazole-3-carboxamide;3-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
CID 160721632

Frequently Asked Questions

What is the IUPAC name of 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide?
The IUPAC name of 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide (CID 161092918) is 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide.
What is the SMILES notation for 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide?
The canonical SMILES for 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide is COc1ccc(S(=O)(=O)N2CCCC2)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.Cc1ccc(COc2occc2C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)cc1.Cn1nc(C(C)(C)C)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1(c2ccccc2)CC1.
What is the InChIKey of 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide?
The InChIKey is UHKMKZZUHBYJFD-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H28N6O4.C27H31N7O5S.C25H26N6O2.C24H30N8O2/c1-18-2-4-19(5-3-18)17-38-28-21(8-11-37-28)27(35)32-24-15-29-33-25(24)26-30-22-7-6-20(14-23(22)31-26)16-34-9-12-36-13-10-34;1-38-24-7-5-19(40(36,37)34-8-2-3-9-34)15-20(24)27(35)31-23-16-28-32-25(23)26-29-21-6-4-18(14-22(21)30-26)17-33-10-12-39-13-11-33;32-24(25(8-9-25)18-4-2-1-3-5-18)29-21-15-26-30-22(21)23-27-19-7-6-17(14-20(19)28-23)16-31-10-12-33-13-11-31;1-24(2,3)20-12-19(31(4)30-20)23(33)28-18-13-25-29-21(18)22-26-16-6-5-15(11-17(16)27-22)14-32-7-9-34-10-8-32/h2-8,11,14-15H,9-10,12-13,16-17H2,1H3,(H,29,33)(H,30,31)(H,32,35);4-7,14-16H,2-3,8-13,17H2,1H3,(H,28,32)(H,29,30)(H,31,35);1-7,14-15H,8-13,16H2,(H,26,30)(H,27,28)(H,29,32);5-6,11-13H,7-10,14H2,1-4H3,(H,25,29)(H,26,27)(H,28,33).
What are the key properties of 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide?
3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide has a molecular weight of 1983.31 g/mol, XLogP of 13.87, 27 rotatable bonds, 12 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 3-tert-butyl-1-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrazole-5-carboxamide;2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-5-pyrrolidin-1-ylsulfonylbenzamide;2-[(4-methylphenyl)methoxy]-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]furan-3-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-phenylcyclopropane-1-carboxamide is sourced from PubChem (CID 161092918), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).